Related references
Note: Only part of the references are listed.Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Lysosomes as dynamic regulators of cell and organismal homeostasis
Andrea Ballabio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA Preliminary Results From a Phase I/II Clinical Treatment Trial
Akosua A. Nti et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Multifaceted roles of ATM in autophagy: From nonselective autophagy to selective autophagy
Nan Liang et al.
CELL BIOCHEMISTRY AND FUNCTION (2019)
Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
Sebastien Miranda et al.
PLOS ONE (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses
Mohammad A. Khanfar' et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer A Phase 2 Randomized Clinical Trial
Thomas B. Karasic et al.
JAMA ONCOLOGY (2019)
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer
Vito W. Rebecca et al.
CANCER DISCOVERY (2019)
An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus
Y. K. Onno Teng et al.
RHEUMATOLOGY (2018)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon et al.
RHEUMATOLOGY (2018)
Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
Weiching Lee et al.
ARTHRITIS CARE & RESEARCH (2018)
Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis A Randomized Trial
Sarah R. Kingsbury et al.
ANNALS OF INTERNAL MEDICINE (2018)
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
Mario Mauthe et al.
AUTOPHAGY (2018)
Joint recommendations for retinal screening in long-term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
I. H. Yusuf et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Autophagy in dendritic cells
Ghita Ghislat et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Clotilde Chatre et al.
DRUG SAFETY (2018)
The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
Imran H. Yusuf et al.
EYE (2018)
Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation
Keagan P. Collins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Hydroxychloroquine-induced restrictive cardiomyopathy: a case report
Muhammad U. Dogar et al.
POSTGRADUATE MEDICAL JOURNAL (2018)
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
Bernardo A. Pons-Estel et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Hydroxychloroquine-induced mimic of renal Fabry disease
C. John Sperati et al.
KIDNEY INTERNATIONAL (2018)
Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease
Shrey Kanvinde et al.
ACTA BIOMATERIALIA (2018)
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care
April Jorge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Hydroxychloroquine-induced autophagic vacuolar myopathy with mitochondrial abnormalities
Shaweta Khosa et al.
NEUROPATHOLOGY (2018)
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires
Nathalie Costedoat-Chalumeau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor
Karin Hjorton et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
Claire Rempenault et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
L. Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hydroxychloroquine in systemic lupus erythematosus (SLE)
C. Ponticelli et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
Entela Nuri et al.
IMMUNOLOGIC RESEARCH (2017)
Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
J. van den Hoek et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis
Chunhui Ma et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study
Konstantinos Tselios et al.
JOURNAL OF RHEUMATOLOGY (2017)
Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
AMAR SRINIVASA et al.
JOURNAL OF RHEUMATOLOGY (2017)
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano et al.
JOURNAL OF RHEUMATOLOGY (2017)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
J. Antonio Avina-Zubieta et al.
ARTHRITIS CARE & RESEARCH (2017)
Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus
Ji Yeon Lee et al.
ARTHRITIS CARE & RESEARCH (2017)
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
Magdalena Circu et al.
PLOS ONE (2017)
Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling
Shu-Fen Wu et al.
ARTHRITIS RESEARCH & THERAPY (2017)
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block
Anna R. Lisney et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review
Kashif Jafri et al.
CLINICAL RHEUMATOLOGY (2017)
Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis
Shi-Qin Wang et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
Ji Yeon Lee et al.
ARTHRITIS & RHEUMATOLOGY (2016)
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Carina Gotestam Skorpen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease
Monique Bethel et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
New Treatment Guidelines for Sjogren's Diseasee
Frederick B. Vivino et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Autophagy Beyond Intracellular MHC Class II Antigen Presentation
Christian Muenz
TRENDS IN IMMUNOLOGY (2016)
Therapeutic Targeting of Autophagy
Christina G. Towers et al.
EBIOMEDICINE (2016)
Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders
Malkeet Singh Bahia et al.
CELLULAR SIGNALLING (2015)
Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase-DNA Interaction
Jie An et al.
JOURNAL OF IMMUNOLOGY (2015)
Paths to a malaria vaccine illuminated by parasite genomics
David J. Conway
TRENDS IN GENETICS (2015)
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
M. Jallouli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
K. D. Rainsford et al.
INFLAMMOPHARMACOLOGY (2015)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
Combined MTOR and autophagy inhibition Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Reshma Rangwala et al.
AUTOPHAGY (2014)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Myrna R. Rosenfeld et al.
AUTOPHAGY (2014)
Prevention and Treatment In Utero of Autoimmune-Associated Congenital Heart Block
Amit Saxena et al.
CARDIOLOGY IN REVIEW (2014)
Rheumatoid arthritis medications and lactation
Lisa R. Sammaritano et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Advances in the understanding and treatment of systemic complications in Sjogren's syndrome
Pilar Brito-Zeron et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview
Sunny Manohar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
The mechanism of double-stranded DNA sensing through the cGAS-STING pathway
Chang Shu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
CANDO and the infinite drug discovery frontier
Mark Minie et al.
DRUG DISCOVERY TODAY (2014)
The Cytosolic DNA Sensor cGAS Forms an Oligomeric Complex with DNA and Undergoes Switch-like Conformational Changes in the Activation Loop
Xu Zhang et al.
CELL REPORTS (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
Mirella P. Hage et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2014)
Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis
Sabrina Dadoun et al.
JOINT BONE SPINE (2013)
The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus
Pooneh S. Akhavan et al.
JOURNAL OF RHEUMATOLOGY (2013)
Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING
Xu Zhang et al.
MOLECULAR CELL (2013)
High-level semi-synthetic production of the potent antimalarial artemisinin
C. J. Paddon et al.
NATURE (2013)
Antimalarial drug discovery - approaches and progress towards new medicines
Erika L. Flannery et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Mobile phones and malaria: Modeling human and parasite travel
Caroline O. Buckee et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
Big Data Opportunities for Global Infectious Disease Surveillance
Simon I. Hay et al.
PLOS MEDICINE (2013)
Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody-Associated Cardiac Manifestations of Neonatal Lupus
Peter M. Izmirly et al.
CIRCULATION (2012)
Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus
N. Ezra et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)
Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy
Andrea Frustaci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort
R. Willis et al.
LUPUS (2012)
Natural products from synthetic biology
Wayne Mitchell
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells
Jamie M. Ireland et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
Pregnancy and reproduction in autoimmune rheumatic diseases
Monika Ostensen et al.
RHEUMATOLOGY (2011)
Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody-Positive Patients
Michelle Petri
CURRENT RHEUMATOLOGY REPORTS (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
T. Groot Kormelink et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation
Ireneusz T. Padol et al.
RHEUMATOLOGY (2010)
The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine
M. R. Namazi
LUPUS (2009)
Predictors of major infections in systemic lupus erythematosus
Guillermo Ruiz-Irastorza et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers
Jacob H. Rand et al.
BLOOD (2008)
Severe hydroxychloroquine myopathy
Hoda Abdel-Hamid et al.
MUSCLE & NERVE (2008)
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Sarah E. Ewald et al.
NATURE (2008)
Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA
D. Ue. Cansu et al.
RHEUMATOLOGY (2008)
Microbially derived artemisnin: A biotechnology solution to the global problem of access to affordable antimalarial drugs
Victoria Hale et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N. Costedoat-Chalumeau et al.
RHEUMATOLOGY (2007)
CYP2C8 and antimalaria drug efficacy
J. P. Gill et al.
PHARMACOGENOMICS (2007)
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms
Masoud Vedadi et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2006)
Incidence of cancer in a cohort of patients with primary Sjogren's syndrome
M. N. Lazarus et al.
RHEUMATOLOGY (2006)
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
J Vollmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
CM Lau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
N Costedoat-Chalumeau et al.
AUTOIMMUNITY REVIEWS (2005)
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
SJ Carmichael et al.
THERAPEUTIC DRUG MONITORING (2003)
Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
XQ Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes
D Projean et al.
XENOBIOTICA (2003)
Cytochrome P4502C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
KA Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
In vitro metabolism of chloroquine:: Identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation
D Projean et al.
DRUG METABOLISM AND DISPOSITION (2003)
Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells
SP Sundelin et al.
APMIS (2002)
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
T Munster et al.
ARTHRITIS AND RHEUMATISM (2002)
Medical need, scientific opportunity and the drive for antimalarial drugs
RG Ridley
NATURE (2002)
Antimalarial drugs in systemic lupus erythematosus - Use in pregnancy
MB Borden et al.
DRUG SAFETY (2001)
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
M Somer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
